Increasing Access to Subsidized Artemisinin-based Combination Therapy through Accredited Drug Dispensing Outlets in Tanzania

Health Research Policy and Systems

Volumn 9, Issue , 2011, Pages

  Rutta, Edmund ^a   Kibassa, Bryceson ^b   McKinnon, Brittany ^c   Liana, Jafary ^d   Mbwasi, Romuald ^d   Mlaki, Wilson ^d   Embrey, Martha ^a   Gabra, Michael ^d   Shekalaghe, Elizabeth ^b   Kimatta, Suleiman ^d   Sillo, Hiiti ^b  

^a MANAGEMENT SCIENCES FOR HEALTH   (United States)

^b Tanzania Food and Drugs Authority   (Tanzania)

^c MCGILL UNIVERSITY   (Canada)

^d Management Sciences for Health   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMISININ; QUININE;

ARTICLE; COMBINATION CHEMOTHERAPY; COST BENEFIT ANALYSIS; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; MALARIA; PHARMACY; PILOT STUDY; PRACTICE GUIDELINE; PROSPECTIVE PRICING; TANZANIA;

EID: 79958053636     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-9-22     Document Type: Article

References (20)

1. Goodman C, Brieger W, Unwin A, Mills A, Meek S, Greer G. Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved?. Am J Trop Med Hyg 2007, 77(6 Suppl):203-18.
2. Goodman C. An economic analysis of the retail market for fever and malaria treatment in rural Tanzania. PhD thesis 2004, London School of Hygiene and Tropical Medicine, University of London. Departement of Public Health and Policy.
3. Tanzania Food and Drug Authority Registered Premises Record. , http://www.tfda.or.tz/pharmacies.php
4. Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A. Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter?. Health Policy Plan 2007, 22(6):393-403.
5. Management Sciences for Health, Strategies for Enhancing Access to Medicines Program Access to Essential Medicines Tanzania 2001 2003, Arlington, VA, Management Sciences for Health, Strategies for Enhancing Access to Medicines Program., http://www.msh.org/SEAM/reports/CR022304_SEAMWebsite_attach1.pdf
6. Rutta E, Senauer K, Johnson K, Adeya G, Mbwasi R, Liana J, Kimatta S, Sigonda M, Alphonce E. Creating a new class of pharmaceutical services provider for underserved areas: the Tanzania accredited drug dispensing outlet experience. Prog Community Health Partnership 2009, 3(2):145-53.
7. Tanzania Ministry of Health and Social Welfare National Guidelines for Malaria Diagnosis and Management 2006, Dar es Salaam, Tanzania Ministry of Health and Social Welfare.
8. Improving Malaria Diagnosis and Treatment in Tanzania: GFATM Proposal R7. , http://portfolio.theglobalfund.org/Grant/Index/TNZ-708-G10-M?lang=en
9. President's Malaria Initiative Malaria Operational Plan (MOP) Tanzania, November 16 2008 2008, Dar es Salaam, President's Malaria Initiative., http://www.fightingmalaria.gov/countries/mops/fy09/tanzania_mop-fy09.pdf
10. Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and Macro International Inc Tanzania HIV/AIDS and Malaria Indicator Survey 2007-08 2008, Dar es Salaam, Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and Macro International Inc.
11. Bosman A, Mendis KN. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Am J Trop Med Hyg 2007, 77(6 Suppl):193-7.
12. Wiseman V, Onwujekwe O, Matovu F, Mutabingwa TK, Whitty CJ. Differences in willingness to pay for artemisinin-based combinations or monotherapy: experiences from the United Republic of Tanzania. Bull World Health Organ 2005, 83(11):845-52.
13. Rutta E. ART Pharmaceutical Management Assessment in Five Missionary Hospitals, Follow up Progress in ADDO Implementation and PMI Work Planning March 2-April 4, 2006 2006, Management Sciences for Health/Rational Pharmaceutical Plus Program. Arlington, VA.
14. Hetzel MW, Iteba N, Makemba A, Mshana C, Lengeler C, Obrist B, Schulze A, Nathan R, Dillip A, Alba S, Mayumana I, Khatib RA, Njau JD, Mshinda H. Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme. Malar J 2007, 29(6):83.
15. Saulo EC, Forsberg BC, Premji Z, Montgomery SM, Björkman A. Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania. Malar J 2008, 31(7):227.
16. Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Lengeler C. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets-- a provider perspective. Malaria J 2010, 9(164):1475-2875.
17. Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, Bishop D, Odhiambo M, Ward L, Goodman C. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS One 2009, 4(9):e6857. District. Management Sciences for Health/Strengthening Pharmaceutical Systems Program. Arlington, VA; 2008..
18. Valimba R, Liana JH, Mwakisu S, Goredema W, Joshi MP. Improving Community Use of Antimicrobials through Private Accredited Drug Dispensing Outlets in Tanzania: Report of a Baseline Assessment Conducted in Kilosa
19. The Global Fund to Fight AIDS, Tuberculosis and Malaria. Affordable Medicines Facility-malaria Frequently Asked Questions. , http://www.theglobalfund.org/documents/amfm/AMFmFAQs_en.pdf
20. Matowe L, Adeyi O. The quest for universal access to effective malaria treatment: how can the AMFm contribute?. Malaria J 2010, 9:274.